Skip to main content
. Author manuscript; available in PMC: 2022 Apr 13.
Published in final edited form as: J Med Chem. 2020 Oct 29;63(21):12957–12977. doi: 10.1021/acs.jmedchem.0c01398

Table 3.

SAR of Pyridazine Wing: Pyridylmethyls

graphic file with name nihms-1794220-t0011.jpg
Compound R GLS
IC50 (nM)a
A549
IC50 (nM)b
Microsomal Stability
(mL/min/kg)c
pH 7.4
Solubility
(μM)d
Hum Rat
14 graphic file with name nihms-1794220-t0012.jpg 71 246 10 3 80
15 graphic file with name nihms-1794220-t0013.jpg 67 643 4 8 33
16 graphic file with name nihms-1794220-t0014.jpg 42 130 4 55 69
17 graphic file with name nihms-1794220-t0015.jpg 49 103 2 0.4 15
18 graphic file with name nihms-1794220-t0016.jpg 22 50 22 16 90
19 graphic file with name nihms-1794220-t0017.jpg 46 86 9 25 91
20 graphic file with name nihms-1794220-t0018.jpg 10 8 23 56 6
a

Inhibition of purified recombinant human GLS-1 (GAC isoform) assessed via a dual-coupled enzyme assay. IC50 values are reported as the mean of at least three determinations. Standard deviations and counts are included in the supporting information.

b

Inhibition of proliferation of A549 cells. IC50 values are reported as the mean of at least three determinations. Standard deviations and counts are included in the supporting information.

c

Liver microsomal intrinsic clearance (mL/min/kg protein).

d

Kinetic aqueous solubility (μM) in phosphate buffer (100 mM) at pH 7.4; shaken for 1 hour at RT.